RxDoctor Payments Data

Dennis Donofrio

Podiatrist · Torrington, CTNPI 1922056951

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,166 of the $2,848 with a category attached, or 76.1%. 19 manufacturers reported payments, led by Organogenesis Inc. at 27.7% of the total. 2025 is the largest year on record at $1,287, 4.6 times the $278 reported in 2019.

$2,848in general payments, 2019–2025

Across 79 payments — averaging $36.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$789
  • Integra Lifesciences Corporation$516
  • Smith+Nephew$301
  • Arthrex$288
  • Kerecis Limited$220
  • Trilliant Surgical LLC.$144
  • plus $590 from 13 others

What the payments were for

  • Travel & lodging$2459%
  • Food & beverage$2,16676%
  • Other$43715%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,848 in reported general payments places this provider in the 80th percentile of 119 podiatrist providers in Connecticut.

See all podiatrist providers in Connecticut

Medicare billing

Part B allowed, 2024
$111,550
Medicare patients
435
Services billed
2,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole130$2,815
Ciclopirox34$1,041
Pregabalin41$614
Gabapentin24$390
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$359
Clindamycin Hcl30$311
Naproxen44$279
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$251
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$118
Levofloxacin20$72

Paid to pharmacies, not to this prescriber.

Other podiatrist in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →